Drug Profile
RO 241882
Latest Information Update: 04 Sep 2000
Price :
$50
*
At a glance
- Originator Roche
- Class Antibacterials; Penicillins
- Mechanism of Action Beta lactamase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Gram-negative infections
Most Recent Events
- 04 Sep 2000 Discontinued-Preclinical for Gram-negative infections in Switzerland (Unknown route)